Qiming-Backed AI Drug Discovery Startup Insilico Medicine Hits Unicorn Status With $110 Million Funding RoundBy Press Room13 March 2025 Insilico Medicine, an AI drug discovery company based in Hong Kong and Boston, has joined the unicorn club after raising…
This Latvian Scientist Says His Startup Is Winning The AI Drug Discovery RaceBy Press Room17 January 2024 In the crowded field of companies racing to discover the next blockbuster drug using artificial intelligence, Hong Kong and New…